Glucotrack to exhibit CBGM at ADCES; touts progress toward US pilot study

Glucotrack, Inc.

Presenting at ADCES Annual Meeting Aug 8-11, 2025 in Phoenix, AZ; CBGM at Booth #1724.
Poster: 'Endocrinologists’ Perspectives on an Implantable CBGM' on Aug 9, 12:00-1:00 PM MST.
Preparing to begin long-term early feasibility study after successful initial clinical validation.
CBGM is fully implantable, lasts up to 3 years, measures blood glucose directly with no on-body wearable.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.